Science Explorer Interactive view Map
Topic · Pulmonary and Respiratory Medicine

Brain Metastases and Treatment

Brain Metastases and Treatment is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 26k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management of brain metastases in cancer patients, including the use of radiosurgery and whole-brain radiation therapy, the impact on cognitive function, prognostic assessment, blood-brain barrier permeability, and specific considerations for HER2-positive breast cancer. It also explores the role of immunotherapy, the effects on neurocognitive function, and the challenges associated with leptomeningeal metastasis.

  • Brain Metastases
  • Radiosurgery
  • Whole-Brain Radiation Therapy
  • Cognitive Function
  • Prognostic Assessment
  • Blood-Brain Barrier
  • HER2-Positive Breast Cancer
  • Immunotherapy
  • Neurocognitive Function
  • Leptomeningeal Metastasis
Research works
26k
fractional, since 1950
In the world top 10%
3.9k
per year above
Top-10% rate
15.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+37%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Brain Metastases and Treatment research?

By volume, the United States and China publish the most (1.8k and 829 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.8k works
  2. 2 China 829 works
  3. 3 Germany 328 works
  4. 4 Japan 317 works
  5. 5 India 217 works
  6. 6 Italy 214 works
  7. 7 United Kingdom 183 works
  8. 8 Canada 165 works
  9. 9 France 163 works
  10. 10 South Korea 121 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.9%China: 19.3%Germany: 7.6%Japan: 7.4%6 others listed: 24.7%41%largest
United States1,758 · 40.9%China829 · 19.3%Germany328 · 7.6%Japan317 · 7.4%6 others listed1,063 · 24.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Brain Metastases and Treatment research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Brain Metastases and Treatment research, followed by Memorial Sloan Kettering Cancer Center and Neurological Surgery.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 63 works
  2. 2 Memorial Sloan Kettering Cancer CenterUnited States 52 works
  3. 3 Neurological SurgeryUnited States 40 works
  4. 4 Moffitt Cancer CenterUnited States 30 works
  5. 5 Stanford UniversityUnited States 30 works
  6. 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 27 works
  7. 7 University of California, San FranciscoUnited States 25 works
  8. 8 University of TorontoCanada 24 works
  9. 9 Harvard UniversityUnited States 22 works
  10. 10 Capital Medical UniversityChina 21 works

Where is Brain Metastases and Treatment research done?

The largest centres of Brain Metastases and Treatment research in 2022–2025 are Beijing (China), New York (United States), Houston (United States) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre, Miami and Heidelberg.

Largest cities, 2022–2025

  1. 1 Beijing China 124 works
  2. 2 New York United States 112 works
  3. 3 Houston United States 90 works
  4. 4 Guangzhou China 90 works
  5. 5 Boston United States 78 works
  6. 6 Shanghai China 75 works
  7. 7 Tokyo Japan 72 works
  8. 8 Toronto Canada 72 works
  9. 9 Seoul South Korea 71 works
  10. 10 Heidelberg Germany 59 works

Where it is the local speciality

  1. Rockville CentreUS · 40.0 works51×
  2. MiamiUS · 46.1 works14×
  3. HeidelbergDE · 58.7 works11×
  4. TampaUS · 38.9 works10×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Brain Metastases and Treatment than the world average.

See Brain Metastases and Treatment on the map

Where is the best place to study Brain Metastases and Treatment?

Among universities, judged by research, Heidelberg University, Harvard University and Shandong First Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.71%fractional works in this node (log) →share in the world top 10% →Heidelberg University: 19, 27.7%Harvard University: 22, 24.1%Shandong First Medical University: 13, 13.6%Medical University of Vienna: 15, 17.9%Chinese Academy of Medical Sciences & Peking Union Medical College: 27, 11.8%University of California, San Francisco: 25, 17.8%Capital Medical University: 21, 14.1%University of Zurich: 9, 27.3%Stanford University: 30, 16.9%Duke University: 19, 15.9%Heidelberg UniversityHarvard UniversityMedical University o…Shandong First Medic…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Heidelberg UniversityGermany 52.827.7%6.6×19 +16.3%
2 Harvard UniversityUnited States 52.124.1%3.2×22 +166.8%
3 Shandong First Medical UniversityChina 52.013.6%9.6×13 +149.7%
4 Medical University of ViennaAustria 51.517.9%9.4×15 +30.5%
5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49.011.8%5.2×27 +202.5%
6 University of California, San FranciscoUnited States 48.617.8%7.4×25 +28.0%
7 Capital Medical UniversityChina 47.914.1%6.9×21 +125.6%
8 University of ZurichSwitzerland 47.627.3%3.3×9 +162.9%
9 Stanford UniversityUnited States 43.716.9%4.6×30 +52.2%
10 Duke UniversityUnited States 40.815.9%5.1×19 +74.9%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Brain Metastases and Treatment research growing?

Output in 2018–2022 was 37% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Brain Metastases and Treatment.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.